DCF — JENNIE STUART MEDICAL CENTER
Enterprise Value: $-171.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-171.4M
Enterprise Value
$-56.4M
PV of Cash Flows
$-115.1M
PV of Terminal Value
$-185.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $170.2M | $-9.5M | -6.0% | $-16.7M | $-15.2M |
| Year 2 | $175.3M | $-8.1M | -5.0% | $-15.5M | $-12.8M |
| Year 3 | $180.6M | $-6.5M | -4.0% | $-14.1M | $-10.6M |
| Year 4 | $186.0M | $-5.8M | -3.0% | $-13.6M | $-9.3M |
| Year 5 | $191.6M | $-5.5M | -3.0% | $-13.6M | $-8.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-171.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$165.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06094978612713794
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5